Please enable JavaScript.
Coggle requires JavaScript to display documents.
36 y.o. lawyer, DM (T2DM (Subtypes (Monogenetic defects of beta cell…
36 y.o. lawyer, DM
T2DM
-
-
-
Subtypes
Monogenetic defects of beta cell function
Early onset of hyperglycemia
Autosomal inheritance
Absence of autoimmunity
Low insulin requirement
Control with sulphonylureas
-
-
Hyperglycemia w/o ketoacidosis, Polyuria, Polydipsia, Nocturia, Blurred vision, weight loss
Therapy
HbA1C<7%
-Nutrition, exercise, patient education
-Metformin
Random blood glucose > 15 mmo/L or blood glucose> 10 mmo/L
HbA1C 7-9%
-Metformin (OR) Sulfonyluria/ DDP4 inhibitor
-Thiazolidinedione dual therapy
HbA1C> 9%
-Metformin + 2nd agent from outset
-Alternative: start insulin
-
-
-
Early and aggressive treatment of DM
-Intensive lifestyle modification
-Tx of hyperlipidemia with statin
-couselling for smoking cessation
-BP control with ARB
-
Gestational Diabetes
Test for T2DM at the 1st prenatal visit
Test for gestational DM at 24-28 weeks of gestation
Screen women with gestational DM for persistatant DM at 6-12 weeks postpartum
Dx of DM
-Casual plasma glucose > 11.1 mmol/L
-Fasting glucose > 7.0 mmol/L
-2 hr post challenge plasma glucose > 11.1 mmol/L
-
-